Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Sulphonylurea Synergy With DPP4 Inhibitors
NCT04192292Completed
- Sponsor
- University of Dundee
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gliclazide and sitagliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by University of Dundee. Primary endpoint: Difference in incretin effect between mixed meal tests. Started Oct 2019; status: completed.
02
Drugs
gliclazidesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04192292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192292.